489 related articles for article (PubMed ID: 29764210)
1. Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.
VanLith C; Guthman R; Nicolas CT; Allen K; Du Z; Joo DJ; Nyberg SL; Lillegard JB; Hickey RD
Hum Gene Ther; 2018 Nov; 29(11):1315-1326. PubMed ID: 29764210
[TBL] [Abstract][Full Text] [Related]
2. Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.
Hickey RD; Mao SA; Glorioso J; Elgilani F; Amiot B; Chen H; Rinaldo P; Marler R; Jiang H; DeGrado TR; Suksanpaisan L; O'Connor MK; Freeman BL; Ibrahim SH; Peng KW; Harding CO; Ho CS; Grompe M; Ikeda Y; Lillegard JB; Russell SJ; Nyberg SL
Sci Transl Med; 2016 Jul; 8(349):349ra99. PubMed ID: 27464750
[TBL] [Abstract][Full Text] [Related]
3. Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats.
Shao Y; Wang L; Guo N; Wang S; Yang L; Li Y; Wang M; Yin S; Han H; Zeng L; Zhang L; Hui L; Ding Q; Zhang J; Geng H; Liu M; Li D
J Biol Chem; 2018 May; 293(18):6883-6892. PubMed ID: 29507093
[TBL] [Abstract][Full Text] [Related]
4. Autologous Gene and Cell Therapy Provides Safe and Long-Term Curative Therapy in A Large Pig Model of Hereditary Tyrosinemia Type 1.
Hickey RD; Nicolas CT; Allen K; Mao S; Elgilani F; Glorioso J; Amiot B; VanLith C; Guthman R; Du Z; Chen H; Harding CO; Kaiser RA; Nyberg SL; Lillegard JB
Cell Transplant; 2019 Jan; 28(1):79-88. PubMed ID: 30477316
[TBL] [Abstract][Full Text] [Related]
5. Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I.
Zhang L; Shao Y; Li L; Tian F; Cen J; Chen X; Hu D; Zhou Y; Xie W; Zheng Y; Ji Y; Liu M; Li D; Hui L
Sci Rep; 2016 Aug; 6():31460. PubMed ID: 27510266
[TBL] [Abstract][Full Text] [Related]
6. Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1.
Li L; Zhang Q; Yang H; Zou Q; Lai C; Jiang F; Zhao P; Luo Z; Yang J; Chen Q; Wang Y; Newsome PN; Frampton J; Maxwell PH; Li W; Chen S; Wang D; Siu TS; Tam S; Tse HF; Qin B; Bao X; Esteban MA; Lai L
J Biol Chem; 2017 Mar; 292(11):4755-4763. PubMed ID: 28053091
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I.
Li N; Gou S; Wang J; Zhang Q; Huang X; Xie J; Li L; Jin Q; Ouyang Z; Chen F; Ge W; Shi H; Liang Y; Zhuang Z; Zhao X; Lian M; Ye Y; Quan L; Wu H; Lai L; Wang K
Mol Ther; 2021 Mar; 29(3):1001-1015. PubMed ID: 33221434
[TBL] [Abstract][Full Text] [Related]
8. Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.
Luijerink MC; van Beurden EA; Malingré HE; Jacobs SM; Grompe M; Klomp LW; Berger R; van den Berg IE
Kidney Int; 2004 Sep; 66(3):990-1000. PubMed ID: 15327392
[TBL] [Abstract][Full Text] [Related]
9. Generation of healthy mice from gene-corrected disease-specific induced pluripotent stem cells.
Wu G; Liu N; Rittelmeyer I; Sharma AD; Sgodda M; Zaehres H; Bleidissel M; Greber B; Gentile L; Han DW; Rudolph C; Steinemann D; Schambach A; Ott M; Schöler HR; Cantz T
PLoS Biol; 2011 Jul; 9(7):e1001099. PubMed ID: 21765802
[TBL] [Abstract][Full Text] [Related]
10. High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice.
Eggenhofer E; Doenecke A; Renner P; Slowik P; Piso P; Geissler EK; Schlitt HJ; Dahlke MH; Popp FC
J Gastroenterol Hepatol; 2010 May; 25(5):1002-8. PubMed ID: 20546455
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models.
Nicolas CT; Hickey RD; Allen KL; Du Z; Guthman RM; Kaiser RA; Amiot B; Bansal A; Pandey MK; Suksanpaisan L; DeGrado TR; Nyberg SL; Lillegard JB
Surgery; 2018 Sep; 164(3):473-481. PubMed ID: 29884476
[TBL] [Abstract][Full Text] [Related]
12.
VanLith CJ; Guthman RM; Nicolas CT; Allen KL; Liu Y; Chilton JA; Tritz ZP; Nyberg SL; Kaiser RA; Lillegard JB; Hickey RD
Hepatol Commun; 2019 Apr; 3(4):558-573. PubMed ID: 30976745
[No Abstract] [Full Text] [Related]
13. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
[TBL] [Abstract][Full Text] [Related]
14. Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo.
Ibraheim R; Tai PWL; Mir A; Javeed N; Wang J; Rodríguez TC; Namkung S; Nelson S; Khokhar ES; Mintzer E; Maitland S; Chen Z; Cao Y; Tsagkaraki E; Wolfe SA; Wang D; Pai AA; Xue W; Gao G; Sontheimer EJ
Nat Commun; 2021 Nov; 12(1):6267. PubMed ID: 34725353
[TBL] [Abstract][Full Text] [Related]
15. In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions.
Nicolas CT; VanLith CJ; Hickey RD; Du Z; Hillin LG; Guthman RM; Cao WJ; Haugo B; Lillegard A; Roy D; Bhagwate A; O'Brien D; Kocher JP; Kaiser RA; Russell SJ; Lillegard JB
Nat Commun; 2022 Aug; 13(1):5012. PubMed ID: 36008405
[TBL] [Abstract][Full Text] [Related]
16. Hepatic lentiviral gene transfer is associated with clonal selection, but not with tumor formation in serially transplanted rodents.
Rittelmeyer I; Rothe M; Brugman MH; Iken M; Schambach A; Manns MP; Baum C; Modlich U; Ott M
Hepatology; 2013 Jul; 58(1):397-408. PubMed ID: 23258554
[TBL] [Abstract][Full Text] [Related]
17. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.
Yin H; Xue W; Chen S; Bogorad RL; Benedetti E; Grompe M; Koteliansky V; Sharp PA; Jacks T; Anderson DG
Nat Biotechnol; 2014 Jun; 32(6):551-3. PubMed ID: 24681508
[TBL] [Abstract][Full Text] [Related]
18. Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I.
Wilber A; Wangensteen KJ; Chen Y; Zhuo L; Frandsen JL; Bell JB; Chen ZJ; Ekker SC; McIvor RS; Wang X
Mol Ther; 2007 Jul; 15(7):1280-7. PubMed ID: 17440442
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.
Yin H; Song CQ; Dorkin JR; Zhu LJ; Li Y; Wu Q; Park A; Yang J; Suresh S; Bizhanova A; Gupta A; Bolukbasi MF; Walsh S; Bogorad RL; Gao G; Weng Z; Dong Y; Koteliansky V; Wolfe SA; Langer R; Xue W; Anderson DG
Nat Biotechnol; 2016 Mar; 34(3):328-33. PubMed ID: 26829318
[TBL] [Abstract][Full Text] [Related]
20. Induced Liver Regeneration Enhances CRISPR/Cas9-Mediated Gene Repair in Tyrosinemia Type 1.
Zhang QS; Tiyaboonchai A; Nygaard S; Baradar K; Major A; Balaji N; Grompe M
Hum Gene Ther; 2021 Mar; 32(5-6):294-301. PubMed ID: 32729326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
